[Latest] Global Dry Eye Syndrome Treatment Market Size/Share Worth USD 12,281.4 Million by 2033 at a 7.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
December 11, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Dry Eye Syndrome Treatment Market Size, Trends and Insights By Type (Evaporative...
[Latest] Global Cardiac Troponin Market Size/Share Worth USD 4.2 Billion by 2033 at a 12.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 09, 2024 04:30 ET
|
Custom Market Insights
Austin, TX, USA, July 09, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cardiac Troponin Market Size, Trends and Insights By Product Type (Cardiac...
[Latest] Global Hereditary Cancer Testing Market Size/Share Worth USD 12.1 Billion by 2033 at a 7.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 02, 2024 14:00 ET
|
Custom Market Insights
Austin, TX, USA, April 02, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hereditary Cancer Testing Market Size, Trends and Insights By Disease Type...
Gabapentin Market revenue to reach USD 6 Billion by 2035, says Research Nester
August 29, 2023 06:00 ET
|
Research Nester
New York, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The gabapentin market size is poised to grow at a CAGR of over ~ 5 % from 2023 to 2035. The market is anticipated to garner a revenue of USD 6 billion by...
AI Therapeutics Announces Investigator Initiated Phase 2 Trial at UCSF to Study LAM-001 in Patients With Bronchiolitis Obliterans Syndrome (BOS) Post-Lung Transplant
August 18, 2023 10:37 ET
|
AI Therapeutics, Inc.
GUILFORD, Conn., Aug. 18, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the commencement...
Global Antinuclear Antibody Test Market Expected to Garner $4,999.40 Million in the 2022-2031 Timeframe, Growing at 14.97% CAGR [300-Pages] | Announced by Research Dive
September 21, 2022 09:03 ET
|
Research Dive
New York, USA, Sept. 21, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global antinuclear antibody test market is predicted to rise at a tremendous CAGR of...